PubRank

Françoise Degos

Author PubWeight™ 72.88‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 International network of cancer genome projects. Nature 2010 20.35
2 Integrated analysis of somatic mutations and focal copy-number changes identifies key genes and pathways in hepatocellular carcinoma. Nat Genet 2012 6.65
3 Longitudinal assessment of histology surrogate markers (FibroTest-ActiTest) during lamivudine therapy in patients with chronic hepatitis B infection. Am J Gastroenterol 2005 2.62
4 [Clinical practice guidelines on the use of liver biopsy]. Gastroenterol Clin Biol 2002 2.22
5 Ultrasonographic surveillance of hepatocellular carcinoma in cirrhosis: a randomized trial comparing 3- and 6-month periodicities. Hepatology 2011 2.14
6 Effect of prolonged interferon therapy on the outcome of hepatitis C virus-related cirrhosis: a randomized trial. Clin Gastroenterol Hepatol 2007 2.08
7 Hepatocellular carcinomas in patients with metabolic syndrome often develop without significant liver fibrosis: a pathological analysis. Hepatology 2009 2.00
8 Obesity and diabetes as a risk factor for hepatocellular carcinoma. Liver Transpl 2004 1.26
9 Glypican-3 expression in hepatocellular tumors: diagnostic value for preneoplastic lesions and hepatocellular carcinomas. Hum Pathol 2006 1.26
10 Accuracy and disagreement of computed tomography and magnetic resonance imaging for the diagnosis of small hepatocellular carcinoma and dysplastic nodules: role of biopsy. Hepatology 2012 1.24
11 Tolerance and outcome of patients with unresectable hepatocellular carcinoma treated with sorafenib. Eur J Gastroenterol Hepatol 2010 1.06
12 Influence of HIV infection on the response to interferon therapy and the long-term outcome of chronic hepatitis B. Gastroenterology 2002 1.06
13 Comparative protein expression profiles of hilar and peripheral hepatic cholangiocarcinomas. J Hepatol 2009 1.04
14 Underestimation of the influence of satellite nodules as a risk factor for post-transplantation recurrence in patients with small hepatocellular carcinoma. Liver Transpl 2004 0.92
15 Prospective evaluation of the management of hepatocellular carcinoma in the elderly. Dig Liver Dis 2011 0.85
16 Liver tumours in patients with Fanconi anaemia: a report of three cases. Eur J Gastroenterol Hepatol 2008 0.85
17 Imaging mass spectrometry provides fingerprints for distinguishing hepatocellular carcinoma from cirrhosis. J Proteome Res 2011 0.83
18 Suspected interaction between sorafenib and HAART in an HIV-1 infected patient: a case report. Hepatogastroenterology 2011 0.80
19 Serum albumin and platelet count but not portal pressure are predictive of death in patients with Child-Pugh A hepatitis C virus-related cirrhosis. Gastroenterol Clin Biol 2005 0.80
20 Global proteomic analysis of microdissected cirrhotic nodules reveals significant biomarkers associated with clonal expansion. Lab Invest 2006 0.79
21 A national collection of liver tumours: lessons learnt from 6 years of biobanking in France. Cancer Lett 2009 0.78
22 Hepatocellular carcinoma and occupation in men: a case-control study. J Occup Environ Med 2008 0.78
23 Hepatocellular carcinoma in human immunodeficiency virus (HIV)-infected patients: is it really different, and if so, why? J Hepatol 2007 0.78
24 [Biological collection of primary liver tumors: a treasure of genes]. Gastroenterol Clin Biol 2003 0.77
25 Incidence of liver abnormalities in Fanconi anemia patients. Am J Hematol 2012 0.76
26 Standardized care management ensures similar survival rates in HIV-positive and HIV-negative patients with hepatocellular carcinoma. J Acquir Immune Defic Syndr 2012 0.76
27 Methods and interest of noninvasive assessment of liver fibrosis are still in debate. Hepatology 2011 0.75